DK0606318T3 - Vanadiumholdige præparater - Google Patents

Vanadiumholdige præparater

Info

Publication number
DK0606318T3
DK0606318T3 DK92920526T DK92920526T DK0606318T3 DK 0606318 T3 DK0606318 T3 DK 0606318T3 DK 92920526 T DK92920526 T DK 92920526T DK 92920526 T DK92920526 T DK 92920526T DK 0606318 T3 DK0606318 T3 DK 0606318T3
Authority
DK
Denmark
Prior art keywords
vanadium
containing preparations
compositions
oxovanadium
monoprotic
Prior art date
Application number
DK92920526T
Other languages
Danish (da)
English (en)
Inventor
John Hugh Mcneill
Hamid Reza Hoveyda
Chris Orvig
Original Assignee
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia filed Critical Univ British Columbia
Application granted granted Critical
Publication of DK0606318T3 publication Critical patent/DK0606318T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DK92920526T 1991-09-30 1992-09-29 Vanadiumholdige præparater DK0606318T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/767,510 US5300496A (en) 1991-09-30 1991-09-30 Complexed vanadium for the treatment of diabetes mellitus
PCT/EP1992/002235 WO1993006811A2 (fr) 1991-09-30 1992-09-29 Compositions contenant du vanadium

Publications (1)

Publication Number Publication Date
DK0606318T3 true DK0606318T3 (da) 1998-09-23

Family

ID=25079727

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92920526T DK0606318T3 (da) 1991-09-30 1992-09-29 Vanadiumholdige præparater

Country Status (13)

Country Link
US (1) US5300496A (fr)
EP (2) EP0811380A3 (fr)
JP (1) JP3515107B2 (fr)
AT (1) ATE162716T1 (fr)
AU (1) AU2649792A (fr)
CA (1) CA2120338A1 (fr)
DE (1) DE69224293T2 (fr)
DK (1) DK0606318T3 (fr)
ES (1) ES2112329T3 (fr)
GR (1) GR3026654T3 (fr)
NZ (1) NZ244569A (fr)
WO (1) WO1993006811A2 (fr)
ZA (1) ZA927522B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866563A (en) * 1991-09-30 1999-02-02 The University Of British Columbia Vanadium compositions
US5527790A (en) * 1991-09-30 1996-06-18 The University Of British Columbia Bis(maltolato)oxovanadium compositions for the treatment of elevated blood sugar
GB9305735D0 (en) * 1993-03-19 1993-05-05 North John R Novel agent for controlling cell activity
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
GB9416767D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
US5863519A (en) * 1994-08-18 1999-01-26 Nycomed Imaging As Composition and method of MRI using both a positive and a negative contrast agent
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
WO1996005867A2 (fr) * 1994-08-18 1996-02-29 Nycomed Imaging A/S Compositions
US5547685A (en) * 1995-05-16 1996-08-20 Eli Lilly And Company Methods for inhibiting bone loss with vanadyl sulfate
US5545661A (en) * 1995-05-16 1996-08-13 Eli Lilly And Company Methods for inhibiting bone loss with bis-pyrone oxovanadium compounds
US5885980A (en) * 1996-06-25 1999-03-23 Enrique G. Gutierrez Composition and method for treating diabetes
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
EP0984971A1 (fr) * 1997-04-24 2000-03-15 Angiotech Pharmaceuticals, Inc. Complexes de vanadium, derives de ces complexes et procedes connexes
US6232340B1 (en) 1997-04-24 2001-05-15 Angiotech Pharmaceuticals, Inc. Vanadium complexes and derivatives thereof and methods related thereto
US6432941B1 (en) 1998-01-20 2002-08-13 Parker Hughes Institute Vanadium compounds for treating cancer
US6245808B1 (en) * 1998-11-05 2001-06-12 Parker Hughes Institute Oxy-vanadium (IV) complexes having spermicidal activity
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
US6852760B1 (en) 1998-09-17 2005-02-08 Akesis Pharmaceuticals, Inc. Compositions and methods for treatment for glucose metabolism disorders
WO2000016782A1 (fr) * 1998-09-18 2000-03-30 The University Of British Columbia Compositions pharmaceutiques de complexes biguanide et vanadium et leur utilisation
WO2000024730A1 (fr) * 1998-10-28 2000-05-04 The University Of British Columbia Complexes organiques de vanadium(iii), et utilisation correspondante
GB2396106B (en) * 2002-12-12 2006-11-15 Johnson & Johnson Medical Ltd Wound dressings comprising enzyme inhibitors
EP1765765A1 (fr) * 2004-07-02 2007-03-28 Genmedica Therapeutics SL Arylalkylamine, sels de vanadium (v) pour le traitement et/ou la prevention du diabete sucre
AU2005315565A1 (en) * 2004-12-16 2006-06-22 Genmedica Therapeutics Sl Amines, combination of amines and vanadium and amine vanadium salts for the treatment or prevention of dyslipidemia
US20070066682A1 (en) * 2005-07-01 2007-03-22 Exposito Miriam R Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus
WO2007131996A1 (fr) * 2006-05-12 2007-11-22 Genmedica Therapeutics Sl Sels de vanadate de méta-xylylène diamine
PL2683374T3 (pl) 2011-03-07 2020-04-30 Cfm Pharma Holding Bv Zastosowanie związków wanadu do utrzymania normoglikemii u ssaków
WO2012131689A1 (fr) 2011-03-25 2012-10-04 Chaudhuri Mihir K Principe actif insulinomimétique comprenant des oxodiperoxovanadates et composition pharmaceutique obtenue à partir de celui-ci
JP7349052B2 (ja) * 2019-06-24 2023-09-22 湖南方升泰医薬科技有限公司 金属錯体の新規応用
CN111035652B (zh) * 2020-01-08 2021-08-24 辽宁大学 钒酸盐酪蛋白复合物在制备降糖药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1277599C (fr) * 1986-10-16 1990-12-11 Barry I. Posner Composes vanadium-peroxyde utilises pour mimer l'insuline
FR2619382B1 (fr) * 1987-08-11 1990-05-04 Lazaro Rene Compose organo-mineral de vanadyle, procede d'obtention d'un tel compose, composition pharmaceutique contenant ce compose organo-mineral
JPH02292217A (ja) * 1989-05-08 1990-12-03 Otsuka Pharmaceut Co Ltd 糖尿病治療薬

Also Published As

Publication number Publication date
NZ244569A (en) 1995-04-27
JPH06511244A (ja) 1994-12-15
ATE162716T1 (de) 1998-02-15
EP0606318A1 (fr) 1994-07-20
US5300496A (en) 1994-04-05
DE69224293D1 (de) 1998-03-05
GR3026654T3 (en) 1998-07-31
WO1993006811A2 (fr) 1993-04-15
ZA927522B (en) 1993-06-16
ES2112329T3 (es) 1998-04-01
JP3515107B2 (ja) 2004-04-05
EP0606318B1 (fr) 1998-01-28
EP0811380A3 (fr) 1999-01-20
CA2120338A1 (fr) 1993-04-15
DE69224293T2 (de) 1998-07-09
WO1993006811A3 (fr) 1993-06-24
EP0811380A2 (fr) 1997-12-10
AU2649792A (en) 1993-05-03

Similar Documents

Publication Publication Date Title
DK0606318T3 (da) Vanadiumholdige præparater
ATE157024T1 (de) Verfahren zur deliquifizierung und zum bleichen von einem ligenocellulosischen material
IL109604A0 (en) Substituted mono- and bipyridylmethyl- pyridones, process for their preparation and pharmaceutical compositions containing them
DE60028376D1 (de) Therapeutische Kombination des Ascorbats mit Lysin und Arginin für Verhinderung und Behandlung des Krebses
DK0851762T3 (da) Farmaceutiske kombinationspræparater, som indeholder erythropoietin og jernpræparater
HU911928D0 (en) Process for the production of chelates and its complexes containing orto ligating functional group, and the medical preparations containing thereof
DE69703228T2 (de) Neue 6-Hydroxy und 6-Oxo-Androstan Verbindungen mit Kardioaktivität und pharmazeutische Präparate davon
ATE305791T1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
ATE25238T1 (de) Pharmazeutische zusammensetzungen zur behandlung von entzuendungen oder arthritis.
DK0977582T3 (da) Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater
DE3575554D1 (de) Aminosaeurederivate mit antitumoraktivitaet sowie diese derivate enthaltende zusammensetzungen.
Kawanishi et al. Mechanism of electron transfer to coordinated dioxygen of oxyhemoglobins to yield peroxide and methemoglobin. Protein control of electron donation by aquopentacyanoferrate (II).
DK0684259T3 (da) L-Lysyl-glycyl-L-histidin og terapeutiske præparater med indhold deraf til sårheling
DE69519049D1 (de) Polymerisationskatalysatoren
MD195C2 (ro) Complecsuri ale cuprului cu proprietăţi antistafilococice
GB1387803A (en) Watersoluble salts of polyhydroxyphenylchromanones
DE3669713D1 (de) Alkylaminoamide und ihre salze, ihre herstellung, ihre verwendung als arzneimittel und diese verbindungen enthaltende zusammensetzungen.
Diemer et al. 2-Acetylpyridinethiosemicarbazone bismuth complexes as therapeutic agents against helicobacter pylori
IL89654A (en) Pharmaceutical combination compositions for treating hypertension
GB1525844A (en) 2-carbamoyl-1,2,4,5-tetrahydro-3h-2-benzazepin-3-ones
DE3160552D1 (en) Medicine containing a biflavanone compound
Letcher (1, 3-bis (2'-pyridylimino) isoindolinato) Ni (II) complexes of phenylcyanamido ligands: crystal structure, solution and spectroscopic properties.
RU98119413A (ru) Способ лечения злокачественных новообразований